Determination of gamma-hydroxybutyrate (GHB), beta-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and gamma-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 885-886, Issue , 2012, Pages 37-42

  Dahl, Sandra Rinne ^a   Olsen, Kirsten Midtbøen ^a   Strand, Dag Helge ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

1,4BD; BHB; GBL; GHB; Pregabalin; UPLC MS MS; Urine; Whole blood

Indexed keywords

1,4BD; BHB; GBL; GHB; PREGABALIN; UPLC-MS/MS; URINE; WHOLE BLOOD;

BUTANE; HIGH PRESSURE LIQUID CHROMATOGRAPHY; SCREENING;

BLOOD;

1,4 BUTANEDIOL; 3 HYDROXYBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; FORMIC ACID; GAMMA BUTYROLACTONE; PREGABALIN;

ARTICLE; BLOOD SAMPLING; DILUTION; FILTRATION; HIGH THROUGHPUT SCREENING; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

3-HYDROXYBUTYRIC ACID; 4-BUTYROLACTONE; BUTYLENE GLYCOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAMMA-AMINOBUTYRIC ACID; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SODIUM OXYBATE; STREET DRUGS; TANDEM MASS SPECTROMETRY;

EID: 84856628887     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.12.009     Document Type: Article

References (39)

1. Al-Samarraie M.S., Karinen R., Mørland J., Stokke O.M. Eur. J. Clin. Pharmacol. 2010, 66:987.
2. Jones A.W., Holmgren A., Kugelberg F.C. Forensic Sci. Med. Pathol. 2008, 4:205.
3. Knudsen K., Jonsson U., Abrahamsson J. Acta Anaesthesiol. Scand. 2010, 54:987.
4. Sellman J.D., Robinson G.M., Beasley R. J. Psychopharmacol. 2009, 23:94.
5. Dean W. (accessed 06.05.11). http://www.erowid.org/chemicals/ghb/ghb_info2.shtml.
6. Nutt D., King L.A., Saulsbury W., Blakemore C. Lancet 2007, 369:1047.
7. Bessman S.P., Fishbein W.N. Nature 1963, 200:1207.
8. Drasbek K.R., Christensen J., Jensen K. Acta Neurol. Scand. 2006, 114:145.
9. Andresen H., Sprys N., Schmoldt A., Mueller A., Iwersen-Bergmann S. Forensic Sci. Int. 2010, 200:93.
10. Andresen H., Aydin B.E., Mueller A., Iwersen-Bergmann S. Drug Test. Anal. 2011, 3:560.
11. Blommel M.L., Blommel A.L. Am. J. Health Syst. Pharm. 2007, 64:1475.
12. Bramness J.G. Tidsskr. Nor. Laegeforen. 2010, 130:1703.
13. Nymdelger S., Nieber K. Med. Monatsschr. Pharm 2007, 30:396.
14. Oulis P., Konstantakopoulos G., Kouzoupis A.V., Masdrakis V.G., Karakatsanis N.A., Karapoulios E., Kontoangelos K.A., Papadimitriou G.N. Hum. Psychopharmacol. 2008, 23:337.
15. D.o.J. Drug Enforcement Administration Fed. Regist. 2005, 70:43633.
16. European Medicines Agency (EMEA). (accessed 06.05.11). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion_-_Variation/human/000546/WC500046605.pdf.
17. Elliott S., Smith C., Cassidy D. Forensic Sci. Int. 2010, 198:53.
18. Denmark L.N. Forensic Sci. Int. 1993, 62:225.
19. Iten P.X., Meier M. J. Forensic Sci. 2000, 45:624.
20. Pounder D.J., Stevenson R.J., Taylor K.K. J. Forensic Sci. 1998, 43:812.
21. Thomsen J.L., Felby S., Theilade P., Nielsen E. Forensic Sci. Int. 1995, 75:163.
22. Norwegian Police. (accessed 06.05.11). https://www.politi.no/vedlegg/lokale_vedlegg/kripos/Vedlegg_782.pdf.
23. T.F. Vedø (accessed 06.05.11). http://sirus.no/filestore/Import_vedlegg/sirusrap.5.09.pdf.
24. Hovda K.E., Bjornaas M.A., Skog K., Opdahl A., Drottning P., Ekeberg O., Jacobsen D. Clin. Toxicol. 2008, 46:35.
25. Chalabianloo F., Schjøtt J. Tidsskr. Nor. Laegeforen. 2009, 129:186.
26. Brown S.D., Melton T.C. Biomed. Chromatogr. 2011, 25:300.
27. Dresen S., Kempf J., Weinmann W. Forensic Sci. Int. 2007, 173:112.
28. Kaufmann E., Alt A. Forensic Sci. Int. 2007, 168:133.
29. Stout P.A., Simons K.D., Kerrigan S. J. Forensic Sci. 2010, 55:531.
30. Mercer J.W., Oldfield L.S., Hoffman K.N., Shakleya D.M., Bell S.C. J. Forensic Sci. 2007, 52:383.
31. Mesmer M.Z., Satzger R.D. J. Forensic Sci. 1998, 43:489.
32. Wood M., Laloup M., Samyn N., Morris M.R., de Bruijn E.A., Maes R.A., Young M.S., Maes V., De Boeck G. J. Chromatogr. A 2004, 1056:83.
33. Johansen S.S., Windberg C.N. J. Anal. Toxicol. 2011, 35:8.
34. Waters. (accessed 09.05.11). http://www.waters.com/waters/nav.htm%3Fcid=513206.
35. Ben-Menachem E. Epilepsia 2004, 45(Suppl. 6):13.
36. Palatini P., Tedeschi L., Frison G., Padrini R., Zordan R., Orlando R., Gallimberti L., Gessa G.L., Ferrara S.D. Eur. J. Clin. Pharmacol. 1993, 45:353.
37. Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, May 2001.
38. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
39. Nishimura H., Moriya F., Hashimoto Y. Forensic Toxicol. 2009, 27:55.